Skip to main navigation

About us Our science Our programs Patients Investors Careers

About us Our science Our programs Patients Investors Careers

Corporate Presentation

Stock Information

Stock Quote & Chart

Corporate Governance

Documents & Charters

Board of Directors

Committee Composition

Financial Information

Quarterly Results

Event Details

APEX Phase 2 Part A 52-Week Results for Zumilokibart (APG777)

Mar 23, 2026 8:00 AM EDT

Supporting Materials

APEX Phase 2 Part A 52-Week Results for Zumilokibart 2.1 MB

to stay updated

Our science Background & Goal Approach Therapeutic Targets Publications

Our programs Pipeline Programs

About us Story & Mission People Contact

Careers Values Benefits Careers

Patients Apogee Commitment Science Simplified Clinical Trials & Disease Ed

Investors Corporate Presentation Overview News & Events Stock Information Corporate Governance Financial Information IR Resources

Terms of Service Privacy Policy Cookies Policy

© 2026 Apogee Therapeutics, Inc. All rights reserved.

Design by Visual Science 2024